Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1950 Sep;29(9):1243–1260. doi: 10.1172/JCI102362

MULTIPLE MYELOMA. III. EFFECT OF URETHANE THERAPY ON PLASMA CELL GROWTH, ABNORMAL SERUM PROTEIN COMPONENTS AND BENCE JONES PROTEINURIA 1

R Wayne Rundles 1,2, M L Dillon 1,2,2, Edith S Dillon 1,2,3
PMCID: PMC436167  PMID: 14774471

Full text

PDF
1243

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMSTRONG J. B. A study of renal function in patients with multiple myeloma. Am J Med Sci. 1950 May;219(5):488–493. doi: 10.1097/00000441-195005000-00003. [DOI] [PubMed] [Google Scholar]
  2. BARR D. P., READER G. G., WHEELER C. H. Cryoglobulinemia; report of two cases with discussion of clinical manifestations, incidence and significance. Ann Intern Med. 1950 Jan;32(1):6-29, illust. doi: 10.7326/0003-4819-32-1-6. [DOI] [PubMed] [Google Scholar]
  3. Blackman S. S., Barker W. H., Buell M. V., Davis B. D. ON THE PATHOGENESIS OF RENAL FAILURE ASSOCIATED WITH MULTIPLE MYELOMA. ELECTROPHORETIC AND CHEMICAL ANALYSIS OF PROTEIN IN URINE AND BLOOD SERUM. J Clin Invest. 1944 Mar;23(2):163–166. doi: 10.1172/JCI101479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dent C. E., Rose G. A. The Bence-Jones protein of multiple myelomatosis: its methionine content and its possible significance in relation to the aetiology of the disease. Biochem J. 1949;44(5):610–618. doi: 10.1042/bj0440610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Devine J. An analysis of Bence-Jones protein. Biochem J. 1941 Mar;35(3):433–445. doi: 10.1042/bj0350433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doljanski L., Rosin A. Studis on the Early Chang in the Livers of Rates Treated with Various Toxic Agents, with Especial Reference to the Vascular Lesions: I. The Histology of the Rat's Liver in Urethane Poisoning. Am J Pathol. 1944 Sep;20(5):945–959. [PMC free article] [PubMed] [Google Scholar]
  7. Gutman A. B., Moore D. H., Gutman E. B., McClellan V., Kabat E. A. FRACTIONATION OF SERUM PROTEINS IN HYPERPROTEINEMIA, WITH SPECIAL REFERENCE TO MULTIPLE MYELOMA. J Clin Invest. 1941 Nov;20(6):765–783. doi: 10.1172/JCI101269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hektoen L., Welker W. H. Immunological differences of crystalline Bence-Jones proteins. Biochem J. 1940 Apr;34(4):487–489. doi: 10.1042/bj0340487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hopkins F. G. A study of Bence-Jones protein, and of the metabolism in three cases of Bence-Jones proteinuria. J Physiol. 1911 Mar 29;42(3):189–250. doi: 10.1113/jphysiol.1911.sp001432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kekwick R. A. The serum proteins in multiple myelomatosis. Biochem J. 1940 Sep;34(8-9):1248–1257. doi: 10.1042/bj0341248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Moore D. H., Kabat E. A., Gutman A. B. BENCE-JONES PROTEINEMIA IN MULTIPLE MYELOMA. J Clin Invest. 1943 Jan;22(1):67–75. doi: 10.1172/JCI101370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Paine T. F., Finland M. Streptomycin-sensitive, -dependent, and -resistant Bacteria. Science. 1948 Feb 6;107(2771):143–144. doi: 10.1126/science.107.2771.143. [DOI] [PubMed] [Google Scholar]
  13. Shapiro S., Ross V., Moore D. H. A VISCOUS PROTEIN OBTAINED IN LARGE AMOUNT FROM THE SERUM OF A PATIENT WITH MULTIPLE MYELOMA. J Clin Invest. 1943 Mar;22(2):137–142. doi: 10.1172/JCI101375. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES